Pfizer COVID jab expanded to US children as young as 12

The Pfizer-BioNTech coronavirus vaccine is being used in multiple countries for teenagers as young as 16.

Coronavirus vaccines will be made available to more children in the United States as regulators on Monday expanded use of the Pfizer-BioNTech jab to those as young as 12, sparking a race to protect students before they head back to class later this year. The jabs could begin to be administered as soon as a US federal vaccine advisory committee issues recommendations for using the two-dose vaccine in 12- to 15-year-olds, expected on May 12. “This is a watershed moment in our ability to fight back the COVID-19 pandemic,” Dr Bill Gruber, a Pfizer senior vice president who is also a paediatrician, told The Associated Press news agency.